John R. Wingard, M.D., director of the Bone Marrow Transplant Program at the University of Florida College of Medicine in Gainesville, has been elected ASBMT vice president, to become president in 2002.
Others winning office in a mail ballot among ASBMT members are:
The new officers and directors were installed at the ASBMT Annual Meeting, March 29-April 1 in Anaheim, Calif.
Also at the Annual Meeting James O. Armitage, M.D., was installed as president, and Richard J. O'Reilly, M.D., assumed the office of president-elect. Dr. Armitage is the newly appointed dean of the University of Nebraska College of Medicine, Omaha. Dr. O'Reilly is chair of the Department of Pediatrics and chief of the Bone Marrow Transplantation Service at Memorial Sloan-Kettering Cancer Center, New York, N.Y.
The new ASBMT president, Dr. Armitage, established the bone marrow transplant program at the University of Nebraska Medical Center in 1982. He has served as chief of the medical center's Section on Oncology and Hematology and chair of the Department of Internal Medicine.
Dr. Armitage completed his undergraduate studies at the University of Nebraska and earned a medical degree from its College of Medicine in 1973. He trained in general internal medicine and in hematology and oncology at the University of Iowa. He is certified by the American Board of Internal Medicine in internal medicine, medical oncology and hematology.
Dr. Armitage has authored or co-authored more than 300 research articles and has been an editor of seven books. He is a past president of the American Society of Clinical Oncology and has served on the ASBMT Board of Directors since 1994.
The ASBMT is a professional association representing the interests of blood and marrow transplantation clinicians and investigators. The society publishes Biology of Blood and Marrow Transplantation, promotes rapid dissemination of basic and clinical research related to hematopoietic stem cell transplantation, and supports clinical guidelines and standards of care for blood and marrow transplant patients.
# # #
The Fred Hutchinson Cancer Research Center is an independent, nonprofit research institution dedicated to the development and advancement of biomedical technology to eliminate cancer and other potentially fatal diseases. Recognized internationally for its pioneering work in bone-marrow transplantation, the Center's four scientific divisions collaborate to form a unique environment for conducting basic and applied science. The Hutchinson Center is the only National Cancer Institute-designated comprehensive cancer center in the Pacific Northwest. For more information, visit the Center's Web site at <www.fhcrc.org>.